Scientists test new HIV Drug's heart safety
NCT ID NCT07305831
Summary
This early-stage study is checking if a new HIV medication called ulonivirine (MK-8507) affects heart rhythm in healthy people. Researchers are measuring how the drug changes a specific heart rhythm interval and tracking how much of the drug stays in the body over time. The study involves 62 healthy volunteers who receive either the drug or a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON Early Phase Services (0001)
San Antonio, Texas, 78209, United States
Conditions
Explore the condition pages connected to this study.